litlas
Log inCreate account

E. Premkumar Reddy

Active 1980–2024

74
Papers
18,897
Citations
67
h-index
74
i10-index

Citations

Citations per year for E. Premkumar Reddy1931: 1 citations1970: 1 citations1979: 1 citations1981: 9 citations1982: 43 citations1983: 170 citations1984: 296 citations1985: 209 citations1986: 230 citations1987: 151 citations1988: 112 citations1989: 75 citations1990: 90 citations1991: 80 citations1992: 53 citations1993: 34 citations1994: 35 citations1995: 38 citations1996: 43 citations1997: 57 citations1998: 54 citations1999: 88 citations2000: 109 citations2001: 93 citations2002: 119 citations2003: 109 citations2004: 92 citations2005: 109 citations2006: 89 citations2007: 113 citations2008: 114 citations2009: 141 citations2010: 126 citations2011: 119 citations2012: 123 citations2013: 103 citations2014: 81 citations2015: 92 citations2016: 92 citations2017: 96 citations2018: 105 citations2019: 350 citations2020: 420 citations2021: 390 citations2022: 282 citations2023: 241 citations2024: 308 citations2025: 150 citations2026: 3 citations1932–1969: no citations, so these years are not shown1971–1978: no citations, so these years are not shown1980: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,647 citing papers, 37.1% of this breakdownChina: 786 citing papers, 11% of this breakdownUnited Kingdom: 371 citing papers, 5.2% of this breakdownGermany: 317 citing papers, 4.5% of this breakdownJapan: 282 citing papers, 4% of this breakdownFrance: 201 citing papers, 2.8% of this breakdownCanada: 184 citing papers, 2.6% of this breakdownItaly: 180 citing papers, 2.5% of this breakdownSpain: 174 citing papers, 2.4% of this breakdownIndia: 160 citing papers, 2.2% of this breakdownSouth Korea: 158 citing papers, 2.2% of this breakdownAustralia: 147 citing papers, 2.1% of this breakdown
0%37.1%Other 21.4%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology44.4%
  • Medicine42%
  • Immunology and Microbiology5.6%
  • Neuroscience1.8%
  • Agricultural and Biological Sciences1.7%
  • Chemistry1%
  • Other3.5%

Topics

  • Cancer-related Molecular Pathways3.7%
  • Ubiquitin and proteasome pathways2.3%
  • Cytokine Signaling Pathways and Interactions2.1%
  • Protein Kinase Regulation and GTPase Signaling1.7%
  • Protein Degradation and Inhibitors1.5%
  • Microtubule and mitosis dynamics1.5%
  • Other87.2%

Coauthors

All papers

Open in search
  1. Drugging the 'undruggable' cancer targets

    Authors: Chi V. Dang, E. Premkumar Reddy, Kevan M. Shokat, Laura Soucek - Nature reviews. Cancer 2017 cited by 907

  2. JNK signaling in apoptosis

    Authors: Danny N. Dhanasekaran, E. Premkumar Reddy - Oncogene 2008 cited by 1,530

  3. TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis

    Authors: Yuhan Xia, Kazuki Inoue, Yong Du, Stacey J. Baker, E. Premkumar Reddy, Matthew B. Greenblatt, Baohong Zhao - Nature Communications 2022 cited by 111

  4. JNK-signaling: A multiplexing hub in programmed cell death

    Authors: Danny N. Dhanasekaran, E. Premkumar Reddy - Genes & Cancer 2017 cited by 362

  5. Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import

    Authors: Verónica Rodríguez-Bravo, Raffaella Pippa, Won-Min Song, Marc Carceles‐Cordon, Ana Dominguez-Andres, Naoto Fujiwara, JungReem Woo, Anna P. Koh, Adam Ertel, Ravi K. Lokareddy, Álvaro Cuesta‐Domínguez, Rosa S. Kim, Irene Rodrı́guez, Peiyao Li, Ronald Gordon, Hadassa Hirschfield, Josep María Prats, E. Premkumar Reddy, Alessandro Fatatis, Daniel P. Petrylak, Leonard G. Gomella, William K. Kelly, Scott W. Lowe, Karen E. Knudsen, Matthew D. Galsky, Gino Cingolani, Amaia Lujambio, Yujin Hoshida, Josep Domingo‐Domenech - Cell 2018 cited by 159

  6. Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease

    Authors: Katsutoshi Sato, Amol Padgaonkar, Stacey J. Baker, Stephen C. Cosenza, Olga Rechkoblit, D. R. C. Venkata Subbaiah, Josep Domingo‐Domenech, Alison Bartkowski, Elisa Port, Aneel K. Aggarwal, M. V. Ramana Reddy, Hanna Y. Irie, E. Premkumar Reddy - Nature Communications 2021 cited by 63

  7. CDK4: a master regulator of the cell cycle and its role in cancer

    Authors: Stacey J. Baker, Poulikos I. Poulikakos, Hanna Y. Irie, Samir Parekh, E. Premkumar Reddy - Genes & Cancer 2022 cited by 83

  8. A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling

    Authors: Sai Krishna Athaluri Divakar, Rodrigo Vasquez‐Del Carpio, Kaushik Dutta, Stacey J. Baker, Stephen C. Cosenza, Indranil Basu, Yogesh K. Gupta, M. V. Ramana Reddy, Lynn Ueno, Jonathan R. Hart, Peter K. Vogt, David J. Mulholland, Chandan Guha, Aneel K. Aggarwal, E. Premkumar Reddy - Cell 2016 cited by 280

  9. Structure of the Gene Encoding the Immunodominant Surface Antigen on the Sporozoite of the Human Malaria Parasite Plasmodium falciparum

    Authors: John B. Dame, Jackie L. Williams, Thomas F. McCutchan, James L. Weber, Robert A. Wirtz, Wayne T. Hockmeyer, W L Maloy, J. David Haynes, Imogene Schneider, Donald R. Roberts, Greg S. Sanders, E. Premkumar Reddy, Carter L. Diggs, Louis H. Miller - Science 1984 cited by 726

  10. JAK/STAT Pathways in Cytokine Signaling and Myeloproliferative Disorders: Approaches for Targeted Therapies

    Authors: Shashi Jatiani, Suzanne J. Baker, L.R. Silverman, E. Premkumar Reddy - Genes & Cancer 2010 cited by 227

  11. Janus kinases: components of multiple signaling pathways

    Authors: Sushil G. Rane, E. Premkumar Reddy - Oncogene 2000 cited by 466

  12. ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent

    Authors: Kiranmai Gumireddy, M. V. Ramana Reddy, Stephen C. Cosenza, R. Boomi Nathan, Stacey J. Baker, Nabisa Papathi, Jian‐Dong Jiang, J. G. Holland, E. Premkumar Reddy - Cancer Cell 2005 cited by 368

  13. CDK4: A Key Player in the Cell Cycle, Development, and Cancer

    Authors: Suzanne J. Baker, E. Premkumar Reddy - Genes & Cancer 2012 cited by 204

  14. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia

    Authors: Andriana G. Kotini, Chan-Jung Chang, Arthur Chow, Han Yuan, Tzu‐Chieh Ho, Tiansu Wang, Shailee Vora, Alexander Solovyov, Chrystel Husser, Malgorzata Olszewska, Julie Teruya‐Feldstein, Deepak Perumal, Virginia M. Klimek, Alexandros Spyridonidis, Raajit K. Rampal, Lewis R. Silverman, E. Premkumar Reddy, Elli Papaemmanuil, Samir Parekh, Benjamin D. Greenbaum, Christina S. Leslie, Michael G. Kharas, Eirini P. Papapetrou - Cell stem cell 2017 cited by 146

  15. Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer

    Authors: Sandra Santasusagna, Shijia Zhu, Vijayakumar Jawalagatti, Marc Carceles-Cordon, Adam Ertel, Saioa Garcia‐Longarte, Won‐Min Song, Naoto Fujiwara, Peiyao Li, Isabel Mendizabal, Daniel P. Petrylak, William K. Kelly, E. Premkumar Reddy, Liguo Wang, Matthew J. Schiewer, Amaia Lujambio, Jeffrey Karnes, Karen E. Knudsen, Carlos Cordon‐Cardo, Haidong Dong, Haojie Huang, Arkaitz Carracedo, Yujin Hoshida, Verónica Rodríguez-Bravo, Josep Domingo‐Domenech - Cancer Discovery 2023 cited by 22

  16. Liver stem cells and hepatocellular carcinoma†

    Authors: Lopa Mishra, Tanuj Banker, Joseph C. Murray, Stephen W. Byers, Arun Thenappan, Aiwu Ruth He, Kirti Shetty, Lynt B. Johnson, E. Premkumar Reddy - Hepatology 2008 cited by 339

  17. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade

    Authors: Chi Yan, Nabil Saleh, Jinming Yang, Caroline A. Nebhan, Anna E. Vilgelm, E. Premkumar Reddy, Joseph T. Roland, Douglas B. Johnson, Sheau‐Chiann Chen, Rebecca L. Shattuck-Brandt, Gregory D. Ayers, Ann Richmond - Molecular Cancer 2021 cited by 39

  18. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene

    Authors: E. Premkumar Reddy, Roberta K. Reynolds, Eugenio Santos, Mariano Barbacid - Nature 1982 cited by 1,397

  19. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia

    Authors: Sushil G. Rane, Pierre Dubus, Richard V. Mettus, Elizabeth J. Galbreath, Guenther Boden, E. Premkumar Reddy, Mariano Barbacid - Nature Genetics 1999 cited by 699

  20. Signaling by dual specificity kinases

    Authors: N. Dhanasekaran, E. Premkumar Reddy - Oncogene 1998 cited by 296

  21. Cell cycle dysregulation in cancer

    Authors: Antonino Glaviano, Samarendra Kumar Singh, E. Hui Clarissa Lee, Elena Okina, Hiu Yan Lam, Daniela Carbone, E. Premkumar Reddy, Mark J. O’Connor, Andrew Koff, Garima Singh, Justin Stebbing, Gautam Sethi, Karen Crasta, Patrizia Diana, Khandan Keyomarsi, Michael B. Yaffe, Seth A. Wander, Aditya Bardia, Alan Prem Kumar - Pharmacological Reviews 2024 cited by 64

  22. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).

    Authors: Xavier Graña, E. Premkumar Reddy - 1995 cited by 1,135

  23. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signaling

    Authors: Yi Tang, Krit Kitisin, Wilma Jogunoori, Cuiling Li, Chu‐Xia Deng, Susette C. Mueller, Habtom W. Ressom, Asif Rashid, Aiwu Ruth He, Jonathan Mendelson, J. Milburn Jessup, Kirti Shetty, Michael Zasloff, Bibhuti Mishra, E. Premkumar Reddy, Lynt B. Johnson, Lopa Mishra - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 307

  24. JAKs, STATs and Src kinases in hematopoiesis

    Authors: Sushil G. Rane, E. Premkumar Reddy - Oncogene 2002 cited by 242